Discovery of respiratory syncytial virus (RSV) fusion inhibitor GS-5806 and clinical proof of concept in a human RSV challenge study

被引：0

作者：

Mackman, Richard L. ^{[1
]}

Sangi, Michael ^{[1
]}

Sperandio, David ^{[1
]}

Parrish, Jay P. ^{[1
]}

Eisenberg, Eugene ^{[2
]}

Perron, Michel ^{[3
]}

Hui, Hon ^{[1
]}

Zhang, Lijun ^{[1
]}

Siegel, Dustin ^{[1
]}

Yang, Hai ^{[1
]}

Saunders, Oliver ^{[1
]}

Boojamra, Constantine ^{[1
]}

Lee, Gary ^{[3
]}

Samuel, Dharmaraj ^{[3
]}

Babaoglu, Kerim ^{[4
]}

Carey, Anne ^{[5
]}

Gilbert, Brian E. ^{[6
]}

Piedra, Pedro A. ^{[6
]}

Strickley, Robert ^{[7
]}

Alfredson, Thomas ^{[7
]}

Iwata, Quynh ^{[7
]}

Toteva, Maria ^{[7
]}

Chan, Johann ^{[7
]}

Wang, Wei K. ^{[2
]}

Hayes, Jaclyn ^{[2
]}

Stray, Kirsten ^{[3
]}

Kincade, April ^{[3
]}

Theodore, Dorothy ^{[3
]}

Jordan, Robert ^{[3
]}

Lewis, Sandy A. ^{[8
]}

Li, Xiaoming ^{[8
]}

O'Riordan, Thomas ^{[8
]}

Kearney, Brian ^{[8
]}

Ramanathan, Srini ^{[8
]}

Jin, Feng ^{[8
]}

Xin, Yan ^{[8
]}

Desai, Manoj ^{[1
]}

Chien, Jason W. ^{[8
]}

Whitley, Richard J. ^{[9
]}

DeVincenzo, John P. ^{[10
]}

Cihlar, Tomas ^{[3
]}

机构：

[1] Gilead Sci Inc, Dept Med Chem, Foster City, CA 94404 USA

[2] Gilead Sci Inc, Dept Drug Metab, Foster City, CA 94404 USA

[3] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA

[4] Gilead Sci Inc, Dept Struct Chem, Foster City, CA 94404 USA

[5] Gilead Sci Inc, Dept Drug Safety Evaluat, Foster City, CA 94404 USA

[6] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA

[7] Gilead Sci Inc, Dept Pharmaceut Dev & Mfg, Foster City, CA 94404 USA

[8] Gilead Sci Inc, Dept Clin Res, Foster City, CA 94404 USA

[9] Univ Alamaba, Sch Med, Birmingham, AL 35924 USA

[10] Univ Tennessee, Sch Med, Memphis, TN 38163 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

352-MEDI

引用

页数：1

共 50 条

[1] Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study
Mackman, Richard L.
Sangi, Michael
Sperandio, David
Parrish, Jay P.
Eisenberg, Eugene
Perron, Michel
Hui, Hon
Zhang, Lijun
Siegel, Dustin
Yang, Hai
Saunders, Oliver
Boojamra, Constantine
Lee, Gary
Samuel, Dharmaraj
Babaoglu, Kerim
Carey, Anne
Gilbert, Brian E.
Piedra, Pedro A.
Strickley, Robert
Iwata, Quynh
Hayes, Jaclyn
Stray, Kirsten
Kinkade, April
Theodore, Dorothy
Jordan, Robert
Desai, Manoj
Cihlar, Tomas
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (04) : 1630 - 1643
[2] Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
DeVincenzo, John P.
Whitley, Richard J.
Mackman, Richard L.
Scaglioni-Weinlich, Cecilia
Harrison, Lisa
Farrell, Eric
McBride, Stephen
Lambkin-Williams, Robert
Jordan, Robert
Xin, Yan
Ramanathan, Srini
O'Riordan, Thomas
Lewis, Sandra A.
Li, Xiaoming
Toback, Seth L.
Lin, Shao-Lee
Chien, Jason W.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08): : 711 - 722
[3] A mechanistic model describing the effect of respiratory syncytial virus (RSV) kinetics on clinical symptom score, and disease attenuation by presatovir (GS-5806)
Lutz, Justin D.
Patel, Kashyap
Smith, Patrick
Chien, Jason W.
Jordan, Robert
Xin, Yan
Ramanathan, Srini
Mathias, Anita
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S64 - S64
[4] A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial of Presatovir (GS-5806), a Novel Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Hospitalized Adults
Hanfelt-Goade, D.
Maimon, N.
Nimer, A.
Riviere, F.
Catherinot, E.
Ison, M.
Jeong, S.
Walsh, E.
Gafter-Gvili, A.
Nama, S.
Napora, P.
Chowers, M.
Bergeron, A.
Zeltser, D.
Moudgil, H.
Limaye, A. P.
Couturaud, F.
Nseir, W.
McKevitt, M.
Porter, D.
Jordan, R.
Guo, Y.
German, P.
Watkins, T. R.
Gossage, D. L.
Chien, J. W.
Falsey, A. R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[5] A Phase 2a Study Demonstrates That Gs-5806 Safely Reduces Viral Load And Clinical Illness In Healthy Adult Volunteers Infected With Respiratory Syncytial Virus (rsv)
DeVincenzo, J.
Whitley, R.
Scaglioni, C.
Harrison, L.
McBride, S.
Mackman, R.
Jordan, R.
Xin, Y.
Ramanathan, S.
O'Riordan, T. G.
Lewis, S.
Toback, S.
Lin, S. -L.
Chien, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[6] GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process
Perron, Michel
Stray, Kirsten
Kinkade, April
Theodore, Dorothy
Lee, Gary
Eisenberg, Eugene
Sangi, Michael
Gilbert, Brian E.
Jordan, Robert
Piedra, Pedro A.
Toms, Geoffery L.
Mackman, Richard
Cihlar, Tomas
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1264 - 1273
[7] GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein
Samuel, Dharmaraj
Xing, Weimei
Niedziela-Majka, Anita
Wong, Jinny S.
Hung, Magdeleine
Brendza, Katherine M.
Perron, Michel
Jordan, Robert
Sperandio, David
Liu, Xiaohong
Mackman, Richard
Sakowicz, Roman
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) : 7109 - 7112
[8] Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection
Jordan, Robert
Shao, Matt
Mackman, Richard L.
Perron, Michel
Cihlar, Tomas
Lewis, Sandy A.
Eisenberg, Eugene J.
Carey, Anne
Strickley, Robert G.
Chien, Jason W.
Anderson, Mark L.
McEligot, Heather A.
Behrens, Nicole E.
Gershwin, Laurel J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4889 - 4900
[9] Burden of Human Respiratory Syncytial Virus (RSV) Infection
Patel, Harshila
Khoury, Hanane
Widjojoatmodjo, Myra
Kolte, Ida
El Khoury, Antoine
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 403 - 403
[10] ACTIVATION OF HUMAN EOSINOPHILS BY RESPIRATORY SYNCYTIAL VIRUS (RSV)
KIMPEN, JLL
GAROFALO, R
WELLIVER, RC
OGRA, PL
PEDIATRIC RESEARCH, 1990, 27 (04) : A158 - A158

← 1 2 3 4 5 →